 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
As PCORI Looks to Finalize Priorities, Commitment to Personalized Rx Remains Unclear
May 16, 2012
As PCORI Looks to Finalize Priorities, Commitment to Personalized Rx Remains Unclear
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- In Draft Research Agenda, PCORI Leaves Room for CER on Personalized Medicine, but Without Specifics
February 1, 2012 / Pharmacogenomics Reporter - In Public Comments, PMC Asks PCORI to be More Specific About How CER and Personalized Rx Align
March 21, 2012 / Pharmacogenomics Reporter - Will PCORI's Patient-Centered Comparative Effectiveness Research Track with Personalized Rx?
March 7, 2012 / Pharmacogenomics Reporter - FDA/CMS Parallel Review of Medical Products Limited Only by Sponsors' Reluctance, CMS Official Says
December 7, 2011 / Pharmacogenomics Reporter - Anticipating Reintroduction of Eshoo Personalized Rx Bill, PMC Hopes to Boost its Chances with Fixes
September 21, 2011 / Pharmacogenomics Reporter